|
시장보고서
상품코드
2055048
엑소좀 연구 시장 : 제품 유형별, 용도별, 질환별, 워크플로우별, 개발 단계별, 최종사용자별, 지역별Exosome Research Market, By Product Type, By Application, By Disease Indication, By Workflow (Isolation Methods and Downstream Analysis, By Development Stage, By End User, By Geography ) |
||||||
엑소좀 연구 시장은 2026년에 3억 3,770만 달러로 추정되며, 2033년에 10억 6,940만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 17.9%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 3억 3,770만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026-2033년까지 예측 기간 CAGR: | 17.90% | 2033년 시장 규모 예측: | 10억 6,940만 달러 |
전 세계 엑소좀 연구 시장은 생명공학 및 생명과학 산업에서 급속히 발전하고 있는 분야로, 세포 간 통신에서 중요한 역할을 하는 나노 규모의 세포외 소포인 엑소좀의 연구와 응용에 중점을 두고 있습니다.
일반적으로 직경 30-150nm 범위의 막으로 둘러싸인 이러한 소포는 다양한 유형의 세포에서 분비되며, 단백질, 지질, 핵산 등 다양한 분자를 내용물로 포함하고 있습니다. 엑소좀은 특히 종양학, 신경학, 재생의학 분야에서 질병 진단용 중요한 바이오마커, 치료 표적, 약물전달 매개체로서 주목받고 있습니다.
이 시장에는 엑소좀 연구에 필수적인 연구 도구, 분리 및 정제 기술, 특성 평가 장비, 분석 서비스가 포함됩니다. 엑소좀의 생물학적 특성과 정밀 의학 분야에서의 잠재력에 대한 이해가 깊어짐에 따라, 제약 회사, 학술 기관, 생명공학 기업들로부터 막대한 투자가 몰리고 있습니다. 이 부문에서는 분리 기술, 분석 기법, 표준화 프로토콜 분야에서 눈부신 기술적 진전이 이루어지고 있으며, 이는 시장 확대를 주도하고 있습니다.
주요 용도 부문은 바이오마커 발견, 치료법 개발, 진단 용도 등, 특히 체액 생검 기술과 맞춤형 의료 접근법에 중점을 두고 있습니다. 이를 통해 엑소좀 연구 시장은 차세대 생물의학 연구 및 임상 적용의 초석으로서의 입지를 확고히 하고 있습니다.
시장 역학
전 세계 엑소좀 연구 시장은 놀라운 성장 잠재력과 연구 및 임상 적용 분야의 광범위한 확산을 뒷받침하는 몇 가지 강력한 시장 촉진요인에 힘입어 성장하고 있습니다. 주요 촉진요인은 전 세계적으로 암 및 신경 질환의 유병률이 증가하고 있다는 점에 기인하며, 이에 따라 새로운 진단 바이오마커와 치료법에 대한 수요가 높아지고 있습니다. 엑소좀은 질환 특이적인 분자 표지자와 비침습적인 검출 능력을 갖추고 있어 유망한 후보로 꼽히고 있습니다. 또한, 엑소좀은 간단한 채혈을 통해 실시간 질환 모니터링 및 치료 반응 평가를 가능하게 한다는 점에서 기존 조직 생검에 비해 우위를 점하고 있어, 액체 생검 기술의 도입 확대 또한 중요한 촉진요인으로 작용하고 있습니다.
또한, 제약 기업과 학술 기관의 연구 개발에 대한 막대한 투자에 더해, 엑소좀 연구 이니셔티브에 대한 정부 자금의 증대가 시장 성장을 가속화하고 있습니다. 그러나 시장에는 표준화된 분리 및 특성 평가 프로토콜의 부재와 같은 뚜렷한 제약이 존재합니다. 이로 인해 연구 결과에 변동이 발생하여, 임상 적용에 있어 규제 당국의 승인이 지연되고 있습니다.
엑소좀의 이질성, 낮은 수율을 보이는 분리법, 분석 기술의 복잡성과 관련된 기술적 과제는 시장 확장에 있어 또 다른 걸림돌이 되고 있습니다. 게다가 전용 장비 및 시약에 따른 높은 비용뿐만 아니라, 최종사용자의 엑소좀 응용에 대한 인식 부족 또한 시장 확산을 제한하고 있습니다. 이러한 과제가 있음에도 불구하고, 약물전달 시스템에서 엑소좀의 응용이 확대됨에 따라 큰 기회가 생겨나고 있습니다. 이는 엑소좀의 자연스러운 생체적합성과 표적화 능력이 합성 운반체에 비해 더 우수한 치료 효과를 가져오기 때문입니다.
맞춤형 의료와 정밀 진단에 대한 관심이 높아짐에 따라, 특히 질환의 조기 발견 및 예후 예측 분야에서 엑소좀을 기반으로 한 바이오마커 개발에 큰 기회가 열리고 있습니다. 한편, 아시아태평양 및 라틴아메리카 신흥 시장에서는 의료 투자 증가와 연구 인프라 확충을 통해 시장 확장에 활용될 수 있는 미개발 잠재력이 존재합니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 주요 지표(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)를 바탕으로 전 세계 엑소좀 연구 시장의 주요 참여 기업들을 분석하고 있습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 전 세계 엑소좀 조사 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 엑소좀 조사 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있습니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 엑소좀 연구 시장 : 제품 유형별, 2021-2033년
제5장 세계의 엑소좀 연구 시장 : 용도별, 2021-2033년
제6장 세계의 엑소좀 연구 시장 : 질환별, 2021-2033년
제7장 세계의 엑소좀 연구 시장 : 워크플로우별, 2021-2033년
제8장 세계의 엑소좀 연구 시장 : 개발 단계별, 2021-2033년
제9장 세계의 엑소좀 연구 시장 : 최종사용자별, 2021-2033년
제10장 세계의 엑소좀 연구 시장 : 지역별, 2021-2033년
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고문헌과 조사 방법
KSM 26.06.18Exosome Research Market is estimated to be valued at USD 337.7 Mn in 2026 and is expected to reach USD 1,069.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 17.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 337.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 17.90% | 2033 Value Projection: | USD 1,069.4 Mn |
The global exosome research market represents a rapidly evolving sector within the biotechnology and life sciences industry, focusing on the study and application of exosomes - nanoscale extracellular vesicles that play crucial roles in intercellular communication.
These membrane-bound vesicles, typically ranging from 30-150 nanometers in diameter, are secreted by various cell types and contain diverse molecular cargo including proteins, lipids, and nucleic acids. Exosomes have emerged as significant biomarkers for disease diagnosis, therapeutic targets, and drug delivery vehicles, particularly in oncology, neurology, and regenerative medicine applications.
The market encompasses research tools, isolation and purification technologies, characterization instruments, and analytical services essential for exosome studies. Growing understanding of exosome biology and their potential in precision medicine has attracted substantial investment from pharmaceutical companies, academic institutions, and biotechnology firms. The field has witnessed remarkable technological advancements in isolation techniques, analytical methodologies, and standardization protocols, driving market expansion.
Key applications span across biomarker discovery, therapeutic development, and diagnostic applications, with particular emphasis on liquid biopsy technologies and personalized medicine approaches, positioning the exosome research market as a cornerstone of next-generation biomedical research and clinical applications.
Market Dynamics
The global exosome research market is propelled by several compelling drivers that underscore its significant growth potential and widespread adoption across research and clinical applications. The primary driver stems from the increasing prevalence of cancer and neurological disorders globally, which has intensified the demand for novel diagnostic biomarkers and therapeutic approaches, positioning exosomes as promising candidates due to their disease-specific molecular signatures and minimal invasive detection capabilities. The rising adoption of liquid biopsy technologies represents another crucial driver, as exosomes offer advantages over traditional tissue biopsies by providing real-time disease monitoring and treatment response assessment through simple blood draws.
Additionally, substantial investments in research and development by pharmaceutical companies and academic institutions, coupled with growing government funding for exosome research initiatives, have accelerated market growth. However, the market faces notable restraints including the lack of standardized isolation and characterization protocols, which creates variability in research outcomes and hinders regulatory approvals for clinical applications.
Technical challenges related to exosome heterogeneity, low yield isolation methods, and the complexity of analytical techniques pose additional barriers to market expansion. Furthermore, high costs associated with specialized equipment and reagents, along with limited awareness among end users about exosome applications, restrict market penetration. Despite these challenges, significant opportunities emerge from the expanding applications of exosomes in drug delivery systems, where their natural biocompatibility and targeting capabilities offer superior therapeutic outcomes compared to synthetic carriers.
The growing focus on personalized medicine and precision diagnostics creates substantial opportunities for exosome-based biomarker development, particularly in early disease detection and prognosis prediction, while emerging markets in Asia Pacific and Latin America present untapped potential for market expansion through increasing healthcare investments and research infrastructure development.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global exosome research market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific, Illumina Inc, Miltenyi Biotec, QIAGEN, Exosome Diagnostics, Lonza Group, Sysmex Corporation, StellaLife Inc, Cell Guidance Systems, Bio-Techne Corporation, Nanosomix, Roche, Cytiva, Nanovision Biosciences, and Luminex Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global exosome research market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global exosome research market
Market Segmentation
- Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Consumables (kits, reagents, columns, beads, cartridges)
- Instruments (e.g., NTA devices, microfluidic devices, Western blot, ELISA instruments)
- Software and Services
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Diagnostics (e.g., cancer biomarker detection, neurological disease diagnostics, liquid biopsy)
- Therapeutics (e.g., drug delivery systems, regenerative medicine, vaccine development)
- Research and Development (basic research, drug discovery, disease mechanism studies)
- Disease Indication Insights (Revenue, USD Mn, 2021 - 2033)
- Oncology
- Neurology/neurodegeneration
- Cardiovascular
- Infectious diseases
- Metabolic/endocrine
- Autoimmune/inflammation
- Reproductive/prenatal
- Others (e.g., dermatology, ophthalmology)
- Workflow Insights (Revenue, USD Mn, 2021 - 2033)
- Isolation Methods
- Ultracentrifugation
- Precipitation
- Immunoaffinity Capture
- Size-Based Isolation
- Microfluidic Techniques
- Downstream Analysis
- Characterization (Particle Size, Concentration, Surface Markers)
- Cell Surface Marker Analysis using Flow Cytometry
- Protein Analysis using Blotting & ELISA
- RNA Analysis with NGS & PCR
- Proteomic Analysis using Mass Spectroscopy
- Others
- Development Stage Insights (Revenue, USD Mn, 2021 - 2033)
- Discovery
- Preclinical
- Clinical I
- Clinical II
- Clinical III
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals and clinical laboratories
- Pharmaceutical & Biotechnology Companies
- Hospitals and Diagnostics Centers
- Government/Non-profit Centers
- Academic and research institutes
- Others (CROs/CMOs)
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific
- Illumina Inc
- Miltenyi Biotec
- QIAGEN
- Exosome Diagnostics
- Lonza Group
- Sysmex Corporation
- StellaLife Inc
- Cell Guidance Systems
- Bio-Techne Corporation
- Nanosomix
- Roche
- Cytiva
- Nanovision Biosciences
- Luminex Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Exosome Research Market, By Product Type
- Global Exosome Research Market, By Application
- Global Exosome Research Market, By Disease Indication
- Global Exosome Research Market, By Workflow
- Global Exosome Research Market, By Development Stage
- Global Exosome Research Market, By End User
- Global Exosome Research Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Exosome Research Market, By Product Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Consumables (kits, reagents, columns, beads, cartridges)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Instruments (e.g., NTA devices, microfluidic devices, Western blot, ELISA instruments)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
5. Global Exosome Research Market, By Application, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Diagnostics (e.g., cancer biomarker detection, neurological disease diagnostics, liquid biopsy)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Therapeutics (e.g., drug delivery systems, regenerative medicine, vaccine development)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Research and Development (basic research, drug discovery, disease mechanism studies)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
6. Global Exosome Research Market, By Disease Indication, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Neurology/neurodegeneration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Infectious diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Metabolic/endocrine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Autoimmune/inflammation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Reproductive/prenatal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others (e.g., dermatology, ophthalmology)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
7. Global Exosome Research Market, By Workflow, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Isolation Methods
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Ultracentrifugation
- Precipitation
- Immunoaffinity Capture
- Size-Based Isolation
- Microfluidic Techniques
- Downstream Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Characterization (Particle Size, Concentration, Surface Markers)
- Cell Surface Marker Analysis using Flow Cytometry
- Protein Analysis using Blotting & ELISA
- RNA Analysis with NGS & PCR
- Proteomic Analysis using Mass Spectroscopy
- Others
8. Global Exosome Research Market, By Development Stage, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Preclinical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Clinical I
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Clinical II
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Clinical III
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
9. Global Exosome Research Market, By End User, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals and clinical laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Hospitals and Diagnostics Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Government/Non-profit Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Academic and research institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others (CROs/CMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
10. Global Exosome Research Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Workflow, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Development Stage, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Workflow, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Development Stage, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Workflow, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Development Stage, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Workflow, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Development Stage, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Workflow, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Development Stage, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Workflow, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Development Stage, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Miltenyi Biotec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Exosome Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sysmex Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- StellaLife Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cell Guidance Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Techne Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nanosomix
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cytiva
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nanovision Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Luminex Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About Us
